Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Expression of the p53, the epidermal growth factor receptor (EGFr; c-erbB-1) and c-erbB-2 proteins was studied in 82 patients with primary transitional cell carcinoma of the bladder using an immuno-histochemical method. Strong or moderate staining was found in 18% of tumours for p53 with weaker stai...
Main Authors: | Wright, C., Mellon, K., Johnston, P., Lane, D. P., Harris, A. L., Horne, C. H., Neal, D. E. |
---|---|
Format: | Online |
Language: | English |
Published: |
1991
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972558/ |
Similar Items
-
Expression of c-erbB-2 protein product in bladder cancer.
by: Wright, C., et al.
Published: (1990) -
Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
by: Coombs, L. M., et al.
Published: (1991) -
Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
by: Mellon, J. K., et al.
Published: (1996) -
Overexpression of mutant p53 and c-erbB-2 proteins and breast tumour take in mice.
by: Mehta, R. R., et al.
Published: (1995) -
Differences in the Binding Affinities of ErbB Family: Heterogeneity in the Prediction of Resistance Mutants
by: Pereira, Mariana, et al.
Published: (2013)